S
arcoidosis is a clinicopathologic syndrome resulting from dispersed organ involvement by a noncaseating granulomatous process of unknown cause. The clinical manifestations of sarcoidosis are protean, depending on the affected organs; however, the principal targets of sarcoidosis are the lungs and thoracic lymph nodes, which almost always are involved. As a rule, it is a disease of insidious onset that pursues a chronic course, with episodic remissions and exacerbations. The severity and diversity of its clinical manifestations depend on the extent of infiltrating granulomatous lesions of the involved organs and that of the number of affected organs. When diffuse and widespread the disease may pursue an acute fulminant course. Diagnosis depends on demonstration of the characteristic pathologic lesion of noncaseating granulomas within the affected organ.
Sarcoidosis is a common (1 to 40 cases per 100,000 population) disease of the relatively young (mean age 40 years), with a proclivity for racial (3.5 times more in blacks), ethnic (Scandinavian), and seasonal occurrence (summer rather than winter). Reports of community outbreaks, work-related risks, familial clustering, occurrence after organ transplantation, and experimental induction in animals by injection of affected tissue homogenates from humans strongly suggests an infective cause that remains to be identified.
Two associated metabolic abnormalities of diagnostic and clinical import are elevated levels of calcitriol (1,25-dihydroxy-vitamin D 3 ) and angiotensin-converting enzyme (ACE). Neither is unique to sarcoidosis. Elevated levels of calcitriol are consequent to the capacity of the infiltrating macrophages of the granulomas to synthesize calcitriol. Elevated levels of ACE are consequent to that of the multinucleated giant and epithelioid cells that ultimately develop in the granulomas, along with that of the infiltrating macrophages, to produce ACE. Of these, the elevated levels of calcitriol are the more important because they account for the abnormal calcium metabolism that occurs in most patients. Elevated levels of ACE are of no known clinical consequence
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Systemic Diseases and the Kidney and are of limited value in diagnosis; however, they can be useful in follow-up of the course of the disease and patient response to treatment.
In symptomatic cases, steroids are highly effective in suppressing the cellular inflammatory reaction of sarcoidosis and in reversing most forms of organ dysfunction caused by granulomatous infiltration. Therapy with prednisone (30 to 40 mg/d) for 8 to 12 weeks, with gradual tapering of the dose (10 to 20 mg/d) over 6 to 12 months, is usually sufficient. Persistent dysfunction can result from residual fibrosis after reversal of the active granulomatous lesions. Close monitoring of patients is essential during tapering and after discontinuation of steroid therapy, because 25% of treated patients experience relapse. Other drugs that have been used in cases unresponsive to steroids are methotrexate, chloroquine, azathioprine, and cyclophosphamide. Of these, methotrexate seems to be more effective.
The prognosis is worse in blacks, the elderly, and those patients who fail to respond to steroids or have extensive multiorgan involvement. 
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Renal Involvement in Sarcoidosis 
FIGURE 8-2
Pathogenesis of granulomatous lesions. Mononuclear cell infiltration is the initial step in the sequence of events that leads to granuloma formation. Recruited macrophages then differentiate into epithelioid and multinucleated giant cells. Activated lymphocytes are interspersed in the evolving lesion and come to form a rim around the granulomas. In time, fibroblasts, mast cells, and collagen fibers begin to encapsulate the mature sarcoid granuloma. Cultured granulomatous homogenates exhibit 1␣-hydroxylase activity and are capable of converting 25-hydroxy-vitamin D 3 to its active 1,25-dihydroxylated form, calcitriol. This capacity resides in the infiltrating macrophages and is not unique to sarcoidosis but a feature of most other granulomatous disorders. Although lacking in specificity to be of diagnostic merit, radioactive gallium scans can be used as noninvasive methods of assessing the activity of sarcoid granulomas. The uptake of radioactive gallium by the macrophages and lymphocytes reflects the activity of the infiltrating cells in affected organs.
CYTOKINES IMPLICATED IN PERPETUATING GRANULOMAS
Interferon-␥ Interleukin-2, 6, and 1␤ Chemoattractants Adhesion molecules Tumor necrosis factor-␣ 
SARCOIDOSIS FREQUENCY OF ORGAN INVOLVEMENT
FIGURE 8-3
Cytokines implicated in perpetuating granulomas. Cytokines released by the infiltrating mononuclear cells and T-cell lymphocytes initiate the cascade of inflammatory reaction that results in subsequent formation of the noncaseating granulomas that characterize sarcoidosis. It is the loss of the otherwise balanced ability of cytokines to modulate the inflammatory response that accounts for the progression of the initial inflammatory reaction to granulomatous formation, and ultimately to the more detrimental process of fibrosis. Macrophages are critical in inducing fibroblasts to proliferate and deposit fibronectin and collagen in the extracellular matrix.
FIGURE 8-4
Frequency of organ involvement. Sarcoidosis is a multisystem disease. Parenchymal involvement by granulomatous lesions is most common in the lungs, whereas that of renal involvement is relatively rare.
